Automatic Classification of Colorectal Polyps Using Probe-based Endomicroscopy With Artificial Intelligence
1 other identifier
interventional
200
1 country
1
Brief Summary
Probe-based confocal laser endomicroscopy (pCLE) is an endoscopic technique that enables real-time histological evaluation of gastrointestinal mucosa during ongoing endoscopy examination. It can predict the classification of Colorectal Polyps accurately. However this requires much experience, which limits the application of pCLE. The investigators designed a computer program using deep neural networks to differentiate hyperplastic from neoplastic polyps automatically in pCLE examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 21, 2018
CompletedFirst Posted
Study publicly available on registry
December 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2019
CompletedDecember 26, 2018
September 1, 2018
9 months
December 21, 2018
December 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The accuracy of classifying colorectal Polyps using Probe-based endomicroscopy with deep neural networks
The primary outcome is to test the diagnostic accuracy, sensitivity, specificity, PPV, NPV of the Artificial Intelligence for diagnosing Colorectal Polyps on real-time pCLE examination.
4 months
Secondary Outcomes (1)
Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists
3 month
Study Arms (2)
AI visible group
EXPERIMENTALAI invisible group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- aged between 18 and 80; agree to give written informed consent.
You may not qualify if:
- Patients under conditions unsuitable for performing CLE including coagulopathy , impaired renal or hepatic function, pregnancy or breastfeeding, and known allergy to fluorescein sodium; Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopic unit of Qilu Hospital Shandong University
Jinan, Shandong, 250001, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president of QiLu Hospital
Study Record Dates
First Submitted
December 21, 2018
First Posted
December 26, 2018
Study Start
May 1, 2018
Primary Completion
January 30, 2019
Study Completion
March 30, 2019
Last Updated
December 26, 2018
Record last verified: 2018-09